Skip to content

8-KAccepted Nov 12, 8:00 AM ET

Imunon: reports Q3 2026 financial results

IMNNImunon, Inc.

Accepted (ET)

8:00 AM

Nov 12, 2026

Filed

Nov 12, 2026

Documents

13

Size

366.7 KB

Summary

Imunon: reports Q3 2026 financial results

Updated

What happened

  • Imunon, Inc. issued a press release on Nov 12, 2026 reporting its financial results for the quarter ended Sep 30, 2026. The press release is furnished as Exhibit 99.1 to the Form 8-K.
  • On Nov 2, 2026, Imunon announced it would hold a conference call on Nov 12, 2026 to discuss its financial results for the quarter ended Sep 30, 2026 and provide a business update. The conference call will be broadcast live on the internet at http://www.imunon.com.
  • The filing states the information is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933. The press release contains forward-looking statements and a cautionary note regarding risks and uncertainties.

Key details

  • Press release date: Nov 12, 2026; quarter covered: quarter ended Sep 30, 2026.
  • Conference call announced: Nov 2, 2026; call date: Nov 12, 2026; webcast: http://www.imunon.com.
  • Press release furnished as Exhibit 99.1 to the Current Report on Form 8-K.
  • The filing explicitly states the furnished information is not "filed" under specified securities laws and includes forward-looking statement caution.

Why it may matter

  • The Form 8-K reports Item 2.02 (results of operations and financial condition), which covers the company’s reported financial results for the quarter ended Sep 30, 2026 and the scheduled discussion of those results on Nov 12, 2026. This filing does not show why the insider traded or why the company acted.

AI-written summary · check the filing